Clin2
NCT06028724Possibly a fitRecruiting

Looking for cancer mutations using a blood test

Solid TumorAdvanced Solid TumorLocally Advanced Solid TumorColon Rectal CancerGastric CancerPancreatic CancerBile Duct CancerHepatocarcinoma

Part of Cancer, Digestive system, Hormones & metabolism, Skin, Women’s health & pregnancy clinical trials.

This study uses a blood test (liquid biopsy) to find genetic changes in advanced solid tumors. It may help doctors choose the right treatment and monitor how well it works over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
782 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older
  • You have been diagnosed with an advanced or locally advanced solid tumor (cancer that has spread or cannot be fully removed by surgery)
  • You are about to start a standard therapy for your cancer type and stage, as listed in the trial
  • You are able to give informed consent and follow the study schedule
  • You have not had another cancer in the last 3 years, except for certain skin cancers or early cervical cancer

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05245136Recruiting
Blood test study for advanced cancer monitoring

This study uses a blood test (liquid biopsy) to look for tumor DNA in patients with advanced cancer. It aims to see if this test can help doctors monitor the cancer and make better treatment decisions.

Augsburg, Bavaria
NCT05334069Recruiting
Blood test study for early cancer detection in patients

This study collects blood from people with cancer and people without cancer (or with possible cancer) to test whether new blood tests can detect cancer earlier. Your blood samples help researchers evaluate how well these tests work.

Anchorage, Alaska
NCT05585684Recruiting
Blood test to guide next cancer treatment choices

This study checks whether a blood test can find tumor genetic changes (called “plasma genomic profiling”) to help choose the best next treatment. It may help your care team decide therapy after your cancer progresses or seems likely to progress soon.

Baltimore, Maryland
NCT03551951Recruiting
Testing cancer cells and DNA in blood, urine, and bone marrow

This study looks for cancer-related cells and DNA in samples like blood, urine, and (for some) bone marrow. The goal is to see whether these tests can help detect or track solid cancers with minimal added procedures.

Columbia, Missouri
NCT07524114Recruiting
Blood test to find leftover cancer after treatment

This study uses a blood test to look for tiny bits of cancer DNA after you finish treatment. It may help doctors know if cancer is still there and guide next steps.

Toronto, Ontario
NCT02906943Recruiting
Testing cancer tissue to guide targeted treatment choices

This trial studies advanced solid tumors by using stored tumor samples to look for molecular clues. The goal is to help doctors better choose cancer treatments that may work for your specific tumor.

Hamilton, Ontario

Hear when a new Solid Tumor trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.